正常人和腺苷脱氨酶缺陷型严重联合免疫缺陷患者的血清腺苷脱氨酶 - Suppr

Suppr

超能文献

Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency.

作者信息

Ratech H, Hirschhorn R

出版信息

Clin Chim Acta. 1981 Sep;115(3):341-7. doi: 10.1016/0009-8981(81)90247-3.

DOI:10.1016/0009-8981(81)90247-3

PMID:6975191

Abstract

摘要

相似文献

Serum adenosine deaminase in normals and in a patient with adenosine deaminase deficient-severe combined immunodeficiency.正常人和腺苷脱氨酶缺陷型严重联合免疫缺陷患者的血清腺苷脱氨酶

Clin Chim Acta. 1981 Sep;115(3):341-7. doi: 10.1016/0009-8981(81)90247-3.

Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.联合免疫缺陷病和腺苷脱氨酶缺乏症患者脾脏中残余腺苷脱氨酶活性的特征分析。

Proc Natl Acad Sci U S A. 1978 Jan;75(1):446-50. doi: 10.1073/pnas.75.1.446.

Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.培养的人淋巴母细胞中一种不同于腺苷脱氨酶的氨基水解酶的特性。

Biochim Biophys Acta. 1981 Apr 14;658(2):280-90. doi: 10.1016/0005-2744(81)90298-9.

Adenosine deaminase deficiency and severe combined immunodeficiency disease.腺苷脱氨酶缺乏症与重症联合免疫缺陷病

Life Sci. 1977 May 15;20(10):1645-50. doi: 10.1016/0024-3205(77)90337-x.

Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.腺苷脱氨酶缺乏症和联合免疫缺陷患者成纤维细胞中残余酶活性的特征：突变酶的证据

Proc Natl Acad Sci U S A. 1976 Jan;73(1):213-7. doi: 10.1073/pnas.73.1.213.

Analysis of normal and mutant forms of human adenosine deaminase - a review.人腺苷脱氨酶正常与突变形式的分析——综述

Mol Cell Biochem. 1980 Feb 8;29(2):91-101. doi: 10.1007/BF00220303.

Adenosine deaminase and immunodeficiency: an in vitro model.

Cell Immunol. 1977 Aug;32(2):350-60. doi: 10.1016/0008-8749(77)90211-8.

Adenosine deaminase activity in normal tissues and tissues from a child with severe combined immunodeficiency and adenosine deaminase deficiency.

Clin Immunol Immunopathol. 1978 Mar;9(3):287-92. doi: 10.1016/0090-1229(78)90100-9.

Lack of adenosine deaminase deficiency in the mutant mouse wasted.突变小鼠中缺乏腺苷脱氨酶导致消瘦。

FEBS Lett. 1986 Nov 24;208(2):431-4. doi: 10.1016/0014-5793(86)81063-8.

[Adenosine deaminase deficiency and severe combined immunodeficiency].腺苷脱氨酶缺乏与重症联合免疫缺陷

Tidsskr Nor Laegeforen. 1980 Feb 20;100(5):274-6.

引用本文的文献

Adenosine Deaminase Inhibitory Activity of Medicinal Plants: Boost the Production of Cordycepin in .药用植物的腺苷脱氨酶抑制活性：促进虫草素的产生。（原文最后“in”后面似乎内容不完整）

Antioxidants (Basel). 2023 Jun 12;12(6):1260. doi: 10.3390/antiox12061260.

Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.血浆腺苷脱氨酶（ADA）-1 和 -2 在人类生命的头四个月表现出稳健的发育变化。

Front Immunol. 2021 May 27;12:578700. doi: 10.3389/fimmu.2021.578700. eCollection 2021.

Human adenosine deaminases ADA1 and ADA2 bind to different subsets of immune cells.人类腺苷脱氨酶ADA1和ADA2与不同亚群的免疫细胞结合。

Cell Mol Life Sci. 2017 Feb;74(3):555-570. doi: 10.1007/s00018-016-2357-0. Epub 2016 Sep 23.

Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity.2 型糖尿病患者腺苷脱氨酶活性的变化及 DPP-4 抑制剂治疗对 ADA 活性的影响。

Diabetes Metab J. 2011 Apr;35(2):149-58. doi: 10.4093/dmj.2011.35.2.149. Epub 2011 Apr 30.

Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.巨噬细胞是炎症反应过程中细胞外腺苷脱氨酶-2的来源。

Clin Exp Immunol. 2004 Oct;138(1):14-20. doi: 10.1111/j.1365-2249.2004.02591.x.

Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections.1型人类嗜T细胞病毒和1型人类免疫缺陷病毒感染患者的腺苷脱氨酶同工酶水平

Clin Diagn Lab Immunol. 1995 Sep;2(5):626-30. doi: 10.1128/cdli.2.5.626-630.1995.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验